SINGAPORE — South-East Asia’s first Illumina Hiseq X is now operational at MedGenome’s lab in Singapore in partnership with Nanyang Technological University Singapore (NTU). To celebrate the launch and completion of first 250 whole genomes, MedGenome today announced a Grant Challenge offering human Whole Genome Sequencing at 30X coverage for USD 199 per genome. Based on […]
–Identifies Tumor-Specific, Clinically Actionable Genetic Alterations to Inform Treatment Decisions with Unparalleled Accuracy– BALTIMORE — Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced the launch of its CancerSELECT™ 125 test for pan-cancer tumor profiling. CancerSELECT 125 identifies clinically actionable and functionally important sequence mutations and structural […]
Global Genomics Leader Builds Health Partnerships SEATTLE — BGI, a leading global genomics organization headquartered inShenzhen, announced it is expanding its international operations with the formation of a new division, BGI Groups USA, to be based in Seattle. BGI is engaged in scientific research, genomic sequencing, precision medicine, agriculture, bioinformatics and related technologies with a vision […]
Mountain View, CA and Ann Arbor, MI—Takara Bio USA Holdings, Inc. (“TBUSH”) and Rubicon Genomics, Inc. (“Rubicon”), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon is a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that F. Hoffman-La Roche Ltd(Roche) has elected to terminate for convenience the development, commercialization and license agreement with Pacific Biosciences for the development and supply of diagnostic products based on the company’s Single Molecule, Real-Time (SMRT®) technology. The agreement, which was entered into by […]
PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has officially notified Pacific Bioscience (PacBio) of its intention to terminate its agreement and efforts to develop a sequencing instrument for use in the clinical research and clinical market using their Single Molecule, Real-Time (SMRT®) technology. With this termination, Roche no longer retains rights […]
QuantuMDx today announced the appointment of CEO Elaine Warburton OBE to the Precision Medicine Catapult Board of Directors as Non Executive Director. Recognised with an OBE in 2014 for her services to Innovation in Healthcare, Elaine will bring 25 years’ of experience in healthcare and biotechnology to the board alongside first-hand experience of the challenges […]
Independent Researchers Declare Maize W22 Line Assembly High Quality and Exceptionally Accurate Ness Ziona, Israel and St Louis, Mo – Dr. Tom Brutnell, Donald Danforth Plant Science Center, in cooperation with a global team of researchers, and NRGene, the leading genomic big data company, announce the accurate assembly of the W22 maize reference genome. “We’re […]
GenDx and Illumina Netherlands BV have recently signed a reseller agreement. According to which GenDx is appointed as a non-exclusive reseller of Illumina products, instruments, such as MiSeq® and MiniSeq® and reagents, as well as maintenance contracts for the field of HLA sequencing in a restricted number of countries, including Benelux, Italy, United Kingdom, Germany […]
Oxford, UK. Oxford Nanopore Technologies Ltd, the UK-based technology company that has designed and sells the world’s only portable DNA/RNA sequencer, has raised £100 million ($126 million) in new funding through a private placement of ordinary shares. The investment round was led by new investor GT Healthcare Capital Partners (“GT Healthcare”), a pan-Asian fund with […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
